Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Oscar Health (NYSE:OSCR) Climbs: Health Insurance Stock Builds Momentum

• In general terms, businesses of this type provide health insurance coverage while emphasizing technology to manage member experience, care coordination, and operations.

Nitish Kishor | 03 July 2026

Kalaris Therapeutics (NASDAQ:KLRS) Rises: Eye Disease Biotech Stock Gets Noticed

• Kalaris Therapeutics describes itself as a clinical-stage biotech developing therapies for retinal and eye diseases.

Nitish Kishor | 03 July 2026

LifeMD (NASDAQ:LFMD) Rises: Digital Health Stock Moves Back Into Focus

• In broad terms, LFMD sits within the digital health group, which focuses on delivering healthcare-related services to consumers through virtual channels.

Nitish Kishor | 03 July 2026

Nutex Health (NASDAQ:NUTX) Climbs: Healthcare Services Stock Moves Higher

• The company describes itself as an operator involved in healthcare facilities and services with a physician-led approach.

Nitish Kishor | 03 July 2026

Agenus (NASDAQ:AGEN) Rises: Immuno-Oncology Stock Draws Market Attention

• Agenus describes itself as an immuno-oncology biotechnology company associated with a pipeline of antibody and vaccine candidates aimed at harnessing the immune system to address cancer.

Nitish Kishor | 03 July 2026

Anixa Biosciences (NASDAQ:ANIX) Climbs: Cancer Biotech Stock Moves Higher

• Anixa Biosciences describes itself as a biotechnology company associated with the development of cancer vaccines and CAR-T immunotherapies, along with diagnostics.

Nitish Kishor | 03 July 2026

Avita Medical (NASDAQ:RCEL) Gains: Regenerative Medicine Stock Moves Higher

• Avita Medical describes itself as a regenerative medicine company associated with commercializing skin-restoration technology.

Nitish Kishor | 03 July 2026

Protagonist Therapeutics (NASDAQ:PTGX) Runs Higher: Is Wall Street Too Excited or Just Catching Up?

• Protagonist Therapeutics is a biopharmaceutical company that specializes in discovering and developing peptide-based therapeutics.

Nitish Kishor | 03 July 2026

Novo Nordisk (NYSE:NVO) Gains Attention: Is the Weight-Loss Drug Leader Back on Investors' Radar?

• Novo Nordisk is a global healthcare company with a long heritage in diabetes care that expanded dramatically into the obesity treatment market through its GLP-1 class of medicines.

Nitish Kishor | 03 July 2026

Neurocrine Biosciences (NASDAQ:NBIX) Draws Attention: Is Specialty Biotech Momentum Building Again?

• Neurocrine Biosciences is a biopharmaceutical company headquartered in San Diego, California, that focuses on discovering, developing, and commercializing treatments for disorders of the nervous system and the endocrine system.

Nitish Kishor | 03 July 2026
Support

Hi! How can we help you today?

Loading…